Alexium International Group Ltd : Alexium Signs US Air Force Agreement

ALEXIUM  INTERNATIONAL  GROUP  LIMITED  ABN:  91  064  820  408  

ASX: AJX ASX/MEDIA RELEASE 3rd January 2012 ALEXIUM AND US AIR FORCE SIGN NEW COOPERATIVE RESEARCH AND DEVELOPMENT AGREEMENT - EXPAND S COLLABORATION FOR MILITARY AND COMMERCIAL APPLICATIONS Perth, WA and Greer, South Carolina, Alexium International Group Limited (Alexium) (ASX:AJX, AX:AJX, OTC QX:AXXIY) is pleased to announce that it has signed a new Cooperative Research and Development Agreement (CRADA) with the US Air Force Research Laboratory (AFRL), Materials and Manufacturing Directorate, Airbase Technologies Division, Tyndall AFB, Florida to continue to develop and commercialize the patented and award winning Reactive Surface Treatment (RST) technology.

This agreement will leverage resources and capabilities of Alexium and the AFRL and advance the effort of developing and transitioning products to the military and civilian markets. Specifically, this collaboration is a joint effort that will explore the RST technology on a variety of materials, integrate nanoparticles developed by the Air Force in various RST treatment applications, and demonstrate a commercially feasible and scalable production process. The outcome of this activity is anticipated to result in greater soldier protection from chemical and biological threats and improved materials used in military and commercial applications.
More recent developments by Alexium have demonstrated significant improvements in RST liquid repellency treatments for chemical/biological protection applications. Cleanshell CB now offers even higher liquid repellency performance, tuned specifically to chemical warfare agent (CWA) simulants such as tributylphosphate (TBP). Outershell fabrics treated with Cleanshell CB protect the outershell fabric from TBP penetration for days. This is a significant improvement and industry step-change over conventional fluorocarbon repellency treatments, which offer only minutes of TBP protection. Cleanshell CB repellency treatment is currently being evaluated at the Army's Natick Soldier Systems Center and Alexium expects to enter US Department of Defense tenders as proposals are invited.
We are also pleased to confirm that Alexium shares will be quoted via American Depositary Receipts (ADR) on a 1 for 10 basis as from 17th January, with Merriman Capital Inc as Principal American Liaison (PAL) and Bank of New York Mellon as the ADR sponsor.

For more information visit: www.alexiuminternational.com

ContactsUnited States Stefan Susta Executive Director
T: [phone]
[e-mail]
Page 1

Australia

Gavin Rezos Nicholas Clark
Chairman CFO & Company Secretary
[e-mail] [e-mail]
T. [phone] T. [phone]
M.+61412898235 M. [phone]
About Alexium
Alexium International Group Limited (ASX:AJX, AX:AJX OTC QX:AXXIY) holds proprietary patent applications for a process developed initially by the US Department of Defense , which allows for the surface modification and attachment of nano particles or multiple chemical functional groups to surfaces or substrates to provide functions such as water proofing, oil proofing, anti-microbial, non-stick and UV protection. Applications under development include but are not limited to textiles, paints, packaging, glass and building materials.
Page 2